A phase I trial of the safety and immunogenicity of a DNA-based vaccine encoding the HER2/neu (HER2) intracellular domain in subjects with HER2+breast cancer.

被引：10

作者：

Disis, Mary L.

Coveler, Andrew L.

Higgins, Doreen

Fintak, Patricia

Waisman, James Ross

Reichow, Jessica

Slota, Meredith

Childs, Jennifer

Dang, Yushe

Salazar, Lupe G.

机构：

[1] Univ Washington, Seattle, WA 98195 USA

[2] City Hope Natl Med Ctr, Duarte, CA 91010 USA

来源：

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.616

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

616

引用

页数：1